Literature DB >> 21459485

A unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH.

Satoshi Futakawa1, Kiyomitsu Nara, Masakazu Miyajima, Atsushi Kuno, Hiromi Ito, Hiroyuki Kaji, Keiro Shirotani, Takashi Honda, Yuriko Tohyama, Kyoka Hoshi, Yusuke Hanzawa, Shinobu Kitazume, Rie Imamaki, Katsutoshi Furukawa, Kazuhiro Tasaki, Hiroyuki Arai, Tatsuhiko Yuasa, Masafumi Abe, Hajime Arai, Hisashi Narimatsu, Yasuhiro Hashimoto.   

Abstract

Idiopathic normal pressure hydrocephalus (iNPH) is an elderly dementia caused by abnormal metabolism in the cerebrospinal fluid (CSF). The tap test is the current basis for confirming iNPH, but it shows very low sensitivity, indicating that many patients who might be cured by a shunt operation will be missed. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, we found two transferrin isoforms: one had a unique N-glycan (Tf-1) whereas the other had N-glycan similar to that of serum transferrin (Tf-2). Glycan analyses revealed that Tf-1 had branching (biantennary) asialo- and agalacto-complex type N-glycans (N-acetylglucosamine [GlcNAc]-terminated glycans), which carried bisecting β1,4-N-acetylglucosamine and core α1,6-fucose. To examine glycoform whether changes in iNPH, we introduced the Tf-2/Tf-1 ratio as a diagnostic index, which minimized blot-to-blot variations in measurement. The Tf-2/Tf-1 ratios of iNPH patients are significantly higher than those of controls (p = 0.0019) and Alzheimer's patients (p = 0.0010). This suggests that the Tf-2/Tf-1 ratio could distinguish iNPH from Alzheimer's disease, and possibly other dementias. In conclusion, glycoform analysis has diagnostic potential in neurological diseases.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21459485     DOI: 10.1016/j.neurobiolaging.2011.02.023

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  16 in total

Review 1.  Automated Chemical Oligosaccharide Synthesis: Novel Approach to Traditional Challenges.

Authors:  Matteo Panza; Salvatore G Pistorio; Keith J Stine; Alexei V Demchenko
Journal:  Chem Rev       Date:  2018-06-28       Impact factor: 60.622

2.  Manual and Automated Syntheses of the N-Linked Glycoprotein Core Glycans.

Authors:  Salvatore G Pistorio; Scott A Geringer; Keith J Stine; Alexei V Demchenko
Journal:  J Org Chem       Date:  2019-05-17       Impact factor: 4.354

3.  Recognition of bisecting N-acetylglucosamine: structural basis for asymmetric interaction with the mouse lectin dendritic cell inhibitory receptor 2.

Authors:  Masamichi Nagae; Kousuke Yamanaka; Shinya Hanashima; Akemi Ikeda; Kana Morita-Matsumoto; Tadashi Satoh; Naoki Matsumoto; Kazuo Yamamoto; Yoshiki Yamaguchi
Journal:  J Biol Chem       Date:  2013-10-09       Impact factor: 5.157

Review 4.  Alteration of Iron Concentration in Alzheimer's Disease as a Possible Diagnostic Biomarker Unveiling Ferroptosis.

Authors:  Eleonora Ficiarà; Zunaira Munir; Silvia Boschi; Maria Eugenia Caligiuri; Caterina Guiot
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

5.  Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus.

Authors:  Madoka Nakajima; Shigeki Yamada; Masakazu Miyajima; Kazunari Ishii; Nagato Kuriyama; Hiroaki Kazui; Hideki Kanemoto; Takashi Suehiro; Kenji Yoshiyama; Masahiro Kameda; Yoshinaga Kajimoto; Mitsuhito Mase; Hisayuki Murai; Daisuke Kita; Teruo Kimura; Naoyuki Samejima; Takahiko Tokuda; Mitsunobu Kaijima; Chihiro Akiba; Kaito Kawamura; Masamichi Atsuchi; Yoshihumi Hirata; Mitsunori Matsumae; Makoto Sasaki; Fumio Yamashita; Shigeki Aoki; Ryusuke Irie; Hiroji Miyake; Takeo Kato; Etsuro Mori; Masatsune Ishikawa; Isao Date; Hajime Arai
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-01-15       Impact factor: 1.742

6.  High Throughput ELISAs to Measure a Unique Glycan on Transferrin in Cerebrospinal Fluid: A Possible Extension toward Alzheimer's Disease Biomarker Development.

Authors:  Keiro Shirotani; Satoshi Futakawa; Kiyomitsu Nara; Kyoka Hoshi; Toshie Saito; Yuriko Tohyama; Shinobu Kitazume; Tatsuhiko Yuasa; Masakazu Miyajima; Hajime Arai; Atsushi Kuno; Hisashi Narimatsu; Yasuhiro Hashimoto
Journal:  Int J Alzheimers Dis       Date:  2011-08-17

7.  A recombinant fungal lectin for labeling truncated glycans on human cancer cells.

Authors:  Aymeric Audfray; Mona Beldjoudi; Adrien Breiman; Amandine Hurbin; Irene Boos; Carlo Unverzagt; Mourad Bouras; Sylvie Lantuejoul; Jean-Luc Coll; Annabelle Varrot; Jacques Le Pendu; Benoit Busser; Anne Imberty
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

8.  PTPRQ as a potential biomarker for idiopathic normal pressure hydrocephalus.

Authors:  Yuki Nagata; Masahiko Bundo; Saiko Sugiura; Masahiro Kamita; Masaya Ono; Kotaro Hattori; Sumiko Yoshida; Yu-Ichi Goto; Katsuya Urakami; Shumpei Niida
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

9.  LW-AFC Effects on N-glycan Profile in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.

Authors:  Jianhui Wang; Xiaorui Cheng; Ju Zeng; Jiangbei Yuan; Zhongfu Wang; Wenxia Zhou; Yongxiang Zhang
Journal:  Aging Dis       Date:  2017-02-01       Impact factor: 6.745

Review 10.  Human plasma protein N-glycosylation.

Authors:  Florent Clerc; Karli R Reiding; Bas C Jansen; Guinevere S M Kammeijer; Albert Bondt; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2015-11-10       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.